GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Earnings per Share (Diluted)

American Cryostem (American Cryostem) Earnings per Share (Diluted) : $-0.07 (TTM As of Jun. 2022)


View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Earnings per Share (Diluted)?

American Cryostem's Earnings per Share (Diluted) for the three months ended in Jun. 2022 was $-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 was $-0.07.

American Cryostem's EPS (Basic) for the three months ended in Jun. 2022 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2022 was $-0.07.

American Cryostem's EPS without NRI for the three months ended in Jun. 2022 was $-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2022 was $-0.06.


American Cryostem Earnings per Share (Diluted) Historical Data

The historical data trend for American Cryostem's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Earnings per Share (Diluted) Chart

American Cryostem Annual Data
Trend Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.03 -0.02 -0.02 -0.05

American Cryostem Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.04 -0.01 -0.02 -0.01

Competitive Comparison of American Cryostem's Earnings per Share (Diluted)

For the Biotechnology subindustry, American Cryostem's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Cryostem's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Cryostem's PE Ratio distribution charts can be found below:

* The bar in red indicates where American Cryostem's PE Ratio falls into.



American Cryostem Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

American Cryostem's Earnings Per Share (Diluted) for the fiscal year that ended in Sep. 2021 is calculated as

Diluted Earnings Per Share (A: Sep. 2021 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.88-0)/60.342
=-0.05

American Cryostem's Earnings Per Share (Diluted) for the quarter that ended in Jun. 2022 is calculated as

Diluted Earnings Per Share (Q: Jun. 2022 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.402-0)/43.995
=-0.01

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


American Cryostem  (OTCPK:CRYO) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


American Cryostem Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of American Cryostem's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


American Cryostem (American Cryostem) Business Description

Traded in Other Exchanges
N/A
Address
1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724
American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.
Executives
John S Arnone director, officer: Chairman 111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski director, officer: COO 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc. 10 percent owner 188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill 10 percent owner 188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina director, 10 percent owner, officer: President and Director 1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915